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Purpose
To assess the reproducibility between the developed
breath-hold black blood and bright blood T2* sequences
for myocardial iron measurement.
Introduction
Early iron detection using myocardial T2* values derived
from Cardiovascular Magnetic Resonance (CMR) has
been reported in significant sized populations [1,2], and
validated [3-6]. Nevertheless, the current bright blood
technique does not provide high contrast between the sig-
nal from the blood pool and that from the myocardium,
and some images appear to have blood signal artifacts and
partial volume effects affecting the myocardium that
would most likely reduce the accuracy of the T2* measure-
ment. The recent development of a T2* sequence with
black blood preparation provides more clearly defined
endocardial borders and reduces artifacts from blood
which affects the myocardial signal measurement and this
has been shown to have improved reproducibility [7].
Although it was demonstrated on 10 patients [7] that the
T2* measurements from both sequences were compara-
ble, it is of clinical interest to compare them on a large
population of patients.
Methods
112 thalassemia patients were studied on a 1.5 T MRI
scanner (Siemens Sonata) using a cardiac phased array
coil and with ECG gating. The study was approved by the
local ethics committee and all patients gave informed
consent.
All patients were scanned using the bright blood [3] and
the black blood [7] T2* sequence subsequently, each
within a breath-hold. A single mid-ventricular short axis
slice was imaged with T2* measured in the left ventricular
septum. The black blood data was analysed by the first
author using the mono-exponential model. The bright
blood data was analysed independently by another expe-
rienced observer using the truncation model [8,9]. The
nonlinear curve fitting algorithm was employed for all the
data analysis (CMRtools, Imperial College London).
Results
Myocardial T2* values ranged from 3 ms to 45 ms (17 ±
11 ms). The mean difference between the bright blood
and black blood T2 values was 0.2 ms indicating no bias.
The coefficient of variation for reproducibility was 5.3%
(Figure 1).
Conclusion
This study demonstrated the good reproducibility
between the breath-hold black blood and the validated
bright blood T2* techniques on a large population of tha-
lassemia patients. Also, no bias between these two meas-
urements was found. It indicates that the black blood T2*
measurement is clinically relevant. Hence, the black
blood T2* measurement is recommended because of its
improved reproducibility. These findings further suggest
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that the T2* technique is reliable for myocardial iron
quantification in patients with iron overload conditions
such as thalassemia.
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Reproducibility between the black blood and the bright blood T2* measurements for 112 thalassemia patientsFigure 1
Reproducibility between the black blood and the bright blood T2* measurements for 112 thalassemia patients. Left: Bland-Alt-
man plot with the line of mean difference and dotted lines as the 95% confidence intervals. Right: scatter plot with the line of 
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